BIOSCIENCE REPORTS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=575961, encodeId=f2915e596122, content=这是直接接受吗？修改都没有。Awaiting Associate Editor Assignment是什么意思？133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , beContent=133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44bb2184804, createdName=效率, createdTime=Sat Sep 07 00:00:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885802, encodeId=f3918858023d, content=小修修回in review15天之后突然时间一变，状态栏变得啥字也没有了是什么情况 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26812404059, createdName=RoseTiger, createdTime=Wed Sep 16 16:06:45 CST 2020, time=2020-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812568, encodeId=d6e981256825, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:1705.0 偏重的研究方向：生物医学;生物综合 经验分享：从2017-2019年的统计结果来看，国人在 Bioscience reports 期刊的发文比例高达 82.254 %，排名第1，排名第二、三的分别是美国和印度，仅仅占比6%和2%。其中国内发表较多的单位有：南京医科大学（35）、中南大学（32）、吉林大学（25）、浙江大学（23）、中山大学（22）等。 我们来看几篇今年发表的论文，平均3个月左右接受，当然有的快一些，有的相对慢一些。整体来说，发文速度还是可以的。 从期刊目前数据来看，除了发文量不断增加以外，Bioscience reports 的各项数据都比较正常，然而因为陷入论文工厂事件，期刊的口碑大大下降，甚至进入某些高校黑名单，建议近期投稿的朋友避开这些期刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Aug 23 21:58:30 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806415, encodeId=ea96806415a2, content=为啥送一审2个月后又变成under associate review了呢，有同样情况的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69c35221125, createdName=1477da0bm07暂无昵称, createdTime=Thu Aug 06 01:06:28 CST 2020, time=2020-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801258, encodeId=550e80125831, content=一审两个多月了，是不是可以催一波了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26812404059, createdName=RoseTiger, createdTime=Sat Jul 04 23:06:22 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589521, encodeId=169c589521c0, content=decision pending后多久有答复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24495253018, createdName=147e61c6m83暂无昵称, createdTime=Thu Apr 23 00:00:00 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799950, encodeId=34f1e9995041, content=作为审稿人毙了一篇纯生信的论文, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/11/496201557c66919dd52c47b9ba68d043.jpg, createdBy=6f902442791, createdName=洛洛仔, createdTime=Fri Jun 26 22:12:21 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591235, encodeId=8b30591235c6, content=这个杂志看运气，运气好，很快，运气不好，一年半载被拒也, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8657105222, createdName=科研二狗, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590839, encodeId=d24e59083931, content=好人一生pingamhanbin0827_86788705 2019-11-05 发表:: 好人一生平安hanbin0827_86788705 2019-11-05 00:00:00 发表: 好人一生平安, beContent=hanbin0827_86788705 2019-11-05 发表:: 好人一生平安, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLp7gHFr6BjdadYu5S0dib1icJX6LFccX1PH9cFmuJITRRTzaIxOvSZNIlQFKnywg2Cribd2PAbkZuGA/132, createdBy=34535244320, createdName=老鱼故事123, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590750, encodeId=aa7c590e503c, content=之后多久送审的呢？初魔 2019-07-01 16:57:00 发表: 我投了35天了，刚刚分到编辑手里边。。。。。。好慢好慢，哎, beContent=初魔 2019-07-01 16:57:00 发表: 我投了35天了，刚刚分到编辑手里边。。。。。。好慢好慢，哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLCGKsTgFGQElarkZHmPicpnkPAFa2qOHBuDT9lsYXiaibBUefKYmThJcHFj0gyrNPicmFe3Qgfw41DAA/132, createdBy=746d5311841, createdName=安琪Christine, createdTime=Wed May 13 00:00:00 CST 2020, time=2020-05-13, status=1, ipAttribution=)]

2019-09-07 效率

这是直接接受吗？修改都没有。Awaiting Associate Editor Assignment是什么意思？133****4826暂无昵称 2019-05-30 00:00:00 发表:
CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04

133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04

131 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=575961, encodeId=f2915e596122, content=这是直接接受吗？修改都没有。Awaiting Associate Editor Assignment是什么意思？133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , beContent=133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44bb2184804, createdName=效率, createdTime=Sat Sep 07 00:00:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885802, encodeId=f3918858023d, content=小修修回in review15天之后突然时间一变，状态栏变得啥字也没有了是什么情况 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26812404059, createdName=RoseTiger, createdTime=Wed Sep 16 16:06:45 CST 2020, time=2020-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812568, encodeId=d6e981256825, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:1705.0 偏重的研究方向：生物医学;生物综合 经验分享：从2017-2019年的统计结果来看，国人在 Bioscience reports 期刊的发文比例高达 82.254 %，排名第1，排名第二、三的分别是美国和印度，仅仅占比6%和2%。其中国内发表较多的单位有：南京医科大学（35）、中南大学（32）、吉林大学（25）、浙江大学（23）、中山大学（22）等。 我们来看几篇今年发表的论文，平均3个月左右接受，当然有的快一些，有的相对慢一些。整体来说，发文速度还是可以的。 从期刊目前数据来看，除了发文量不断增加以外，Bioscience reports 的各项数据都比较正常，然而因为陷入论文工厂事件，期刊的口碑大大下降，甚至进入某些高校黑名单，建议近期投稿的朋友避开这些期刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Aug 23 21:58:30 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806415, encodeId=ea96806415a2, content=为啥送一审2个月后又变成under associate review了呢，有同样情况的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69c35221125, createdName=1477da0bm07暂无昵称, createdTime=Thu Aug 06 01:06:28 CST 2020, time=2020-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801258, encodeId=550e80125831, content=一审两个多月了，是不是可以催一波了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26812404059, createdName=RoseTiger, createdTime=Sat Jul 04 23:06:22 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589521, encodeId=169c589521c0, content=decision pending后多久有答复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24495253018, createdName=147e61c6m83暂无昵称, createdTime=Thu Apr 23 00:00:00 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799950, encodeId=34f1e9995041, content=作为审稿人毙了一篇纯生信的论文, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/11/496201557c66919dd52c47b9ba68d043.jpg, createdBy=6f902442791, createdName=洛洛仔, createdTime=Fri Jun 26 22:12:21 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591235, encodeId=8b30591235c6, content=这个杂志看运气，运气好，很快，运气不好，一年半载被拒也, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8657105222, createdName=科研二狗, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590839, encodeId=d24e59083931, content=好人一生pingamhanbin0827_86788705 2019-11-05 发表:: 好人一生平安hanbin0827_86788705 2019-11-05 00:00:00 发表: 好人一生平安, beContent=hanbin0827_86788705 2019-11-05 发表:: 好人一生平安, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLp7gHFr6BjdadYu5S0dib1icJX6LFccX1PH9cFmuJITRRTzaIxOvSZNIlQFKnywg2Cribd2PAbkZuGA/132, createdBy=34535244320, createdName=老鱼故事123, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590750, encodeId=aa7c590e503c, content=之后多久送审的呢？初魔 2019-07-01 16:57:00 发表: 我投了35天了，刚刚分到编辑手里边。。。。。。好慢好慢，哎, beContent=初魔 2019-07-01 16:57:00 发表: 我投了35天了，刚刚分到编辑手里边。。。。。。好慢好慢，哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLCGKsTgFGQElarkZHmPicpnkPAFa2qOHBuDT9lsYXiaibBUefKYmThJcHFj0gyrNPicmFe3Qgfw41DAA/132, createdBy=746d5311841, createdName=安琪Christine, createdTime=Wed May 13 00:00:00 CST 2020, time=2020-05-13, status=1, ipAttribution=)]

2020-09-16 RoseTiger

小修修回in review15天之后突然时间一变，状态栏变得啥字也没有了是什么情况

97 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=575961, encodeId=f2915e596122, content=这是直接接受吗？修改都没有。Awaiting Associate Editor Assignment是什么意思？133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , beContent=133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44bb2184804, createdName=效率, createdTime=Sat Sep 07 00:00:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885802, encodeId=f3918858023d, content=小修修回in review15天之后突然时间一变，状态栏变得啥字也没有了是什么情况 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26812404059, createdName=RoseTiger, createdTime=Wed Sep 16 16:06:45 CST 2020, time=2020-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812568, encodeId=d6e981256825, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:1705.0 偏重的研究方向：生物医学;生物综合 经验分享：从2017-2019年的统计结果来看，国人在 Bioscience reports 期刊的发文比例高达 82.254 %，排名第1，排名第二、三的分别是美国和印度，仅仅占比6%和2%。其中国内发表较多的单位有：南京医科大学（35）、中南大学（32）、吉林大学（25）、浙江大学（23）、中山大学（22）等。 我们来看几篇今年发表的论文，平均3个月左右接受，当然有的快一些，有的相对慢一些。整体来说，发文速度还是可以的。 从期刊目前数据来看，除了发文量不断增加以外，Bioscience reports 的各项数据都比较正常，然而因为陷入论文工厂事件，期刊的口碑大大下降，甚至进入某些高校黑名单，建议近期投稿的朋友避开这些期刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Aug 23 21:58:30 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806415, encodeId=ea96806415a2, content=为啥送一审2个月后又变成under associate review了呢，有同样情况的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69c35221125, createdName=1477da0bm07暂无昵称, createdTime=Thu Aug 06 01:06:28 CST 2020, time=2020-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801258, encodeId=550e80125831, content=一审两个多月了，是不是可以催一波了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26812404059, createdName=RoseTiger, createdTime=Sat Jul 04 23:06:22 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589521, encodeId=169c589521c0, content=decision pending后多久有答复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24495253018, createdName=147e61c6m83暂无昵称, createdTime=Thu Apr 23 00:00:00 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799950, encodeId=34f1e9995041, content=作为审稿人毙了一篇纯生信的论文, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/11/496201557c66919dd52c47b9ba68d043.jpg, createdBy=6f902442791, createdName=洛洛仔, createdTime=Fri Jun 26 22:12:21 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591235, encodeId=8b30591235c6, content=这个杂志看运气，运气好，很快，运气不好，一年半载被拒也, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8657105222, createdName=科研二狗, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590839, encodeId=d24e59083931, content=好人一生pingamhanbin0827_86788705 2019-11-05 发表:: 好人一生平安hanbin0827_86788705 2019-11-05 00:00:00 发表: 好人一生平安, beContent=hanbin0827_86788705 2019-11-05 发表:: 好人一生平安, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLp7gHFr6BjdadYu5S0dib1icJX6LFccX1PH9cFmuJITRRTzaIxOvSZNIlQFKnywg2Cribd2PAbkZuGA/132, createdBy=34535244320, createdName=老鱼故事123, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590750, encodeId=aa7c590e503c, content=之后多久送审的呢？初魔 2019-07-01 16:57:00 发表: 我投了35天了，刚刚分到编辑手里边。。。。。。好慢好慢，哎, beContent=初魔 2019-07-01 16:57:00 发表: 我投了35天了，刚刚分到编辑手里边。。。。。。好慢好慢，哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLCGKsTgFGQElarkZHmPicpnkPAFa2qOHBuDT9lsYXiaibBUefKYmThJcHFj0gyrNPicmFe3Qgfw41DAA/132, createdBy=746d5311841, createdName=安琪Christine, createdTime=Wed May 13 00:00:00 CST 2020, time=2020-05-13, status=1, ipAttribution=)]

2020-08-23 lovetcm

审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:1705.0
偏重的研究方向：生物医学;生物综合
经验分享：从2017-2019年的统计结果来看，国人在 Bioscience reports 期刊的发文比例高达 82.254 %，排名第1，排名第二、三的分别是美国和印度，仅仅占比6%和2%。其中国内发表较多的单位有：南京医科大学（35）、中南大学（32）、吉林大学（25）、浙江大学（23）、中山大学（22）等。
我们来看几篇今年发表的论文，平均3个月左右接受，当然有的快一些，有的相对慢一些。整体来说，发文速度还是可以的。
从期刊目前数据来看，除了发文量不断增加以外，Bioscience reports 的各项数据都比较正常，然而因为陷入论文工厂事件，期刊的口碑大大下降，甚至进入某些高校黑名单，建议近期投稿的朋友避开这些期刊！

116 0

[GetPortalCommentsPageByObjectIdResponse(id=575961, encodeId=f2915e596122, content=这是直接接受吗？修改都没有。Awaiting Associate Editor Assignment是什么意思？133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , beContent=133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44bb2184804, createdName=效率, createdTime=Sat Sep 07 00:00:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885802, encodeId=f3918858023d, content=小修修回in review15天之后突然时间一变，状态栏变得啥字也没有了是什么情况 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26812404059, createdName=RoseTiger, createdTime=Wed Sep 16 16:06:45 CST 2020, time=2020-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812568, encodeId=d6e981256825, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:1705.0 偏重的研究方向：生物医学;生物综合 经验分享：从2017-2019年的统计结果来看，国人在 Bioscience reports 期刊的发文比例高达 82.254 %，排名第1，排名第二、三的分别是美国和印度，仅仅占比6%和2%。其中国内发表较多的单位有：南京医科大学（35）、中南大学（32）、吉林大学（25）、浙江大学（23）、中山大学（22）等。 我们来看几篇今年发表的论文，平均3个月左右接受，当然有的快一些，有的相对慢一些。整体来说，发文速度还是可以的。 从期刊目前数据来看，除了发文量不断增加以外，Bioscience reports 的各项数据都比较正常，然而因为陷入论文工厂事件，期刊的口碑大大下降，甚至进入某些高校黑名单，建议近期投稿的朋友避开这些期刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Aug 23 21:58:30 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806415, encodeId=ea96806415a2, content=为啥送一审2个月后又变成under associate review了呢，有同样情况的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69c35221125, createdName=1477da0bm07暂无昵称, createdTime=Thu Aug 06 01:06:28 CST 2020, time=2020-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801258, encodeId=550e80125831, content=一审两个多月了，是不是可以催一波了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26812404059, createdName=RoseTiger, createdTime=Sat Jul 04 23:06:22 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589521, encodeId=169c589521c0, content=decision pending后多久有答复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24495253018, createdName=147e61c6m83暂无昵称, createdTime=Thu Apr 23 00:00:00 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799950, encodeId=34f1e9995041, content=作为审稿人毙了一篇纯生信的论文, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/11/496201557c66919dd52c47b9ba68d043.jpg, createdBy=6f902442791, createdName=洛洛仔, createdTime=Fri Jun 26 22:12:21 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591235, encodeId=8b30591235c6, content=这个杂志看运气，运气好，很快，运气不好，一年半载被拒也, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8657105222, createdName=科研二狗, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590839, encodeId=d24e59083931, content=好人一生pingamhanbin0827_86788705 2019-11-05 发表:: 好人一生平安hanbin0827_86788705 2019-11-05 00:00:00 发表: 好人一生平安, beContent=hanbin0827_86788705 2019-11-05 发表:: 好人一生平安, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLp7gHFr6BjdadYu5S0dib1icJX6LFccX1PH9cFmuJITRRTzaIxOvSZNIlQFKnywg2Cribd2PAbkZuGA/132, createdBy=34535244320, createdName=老鱼故事123, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590750, encodeId=aa7c590e503c, content=之后多久送审的呢？初魔 2019-07-01 16:57:00 发表: 我投了35天了，刚刚分到编辑手里边。。。。。。好慢好慢，哎, beContent=初魔 2019-07-01 16:57:00 发表: 我投了35天了，刚刚分到编辑手里边。。。。。。好慢好慢，哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLCGKsTgFGQElarkZHmPicpnkPAFa2qOHBuDT9lsYXiaibBUefKYmThJcHFj0gyrNPicmFe3Qgfw41DAA/132, createdBy=746d5311841, createdName=安琪Christine, createdTime=Wed May 13 00:00:00 CST 2020, time=2020-05-13, status=1, ipAttribution=)]

2020-08-06 1477da0bm07暂无昵称

为啥送一审2个月后又变成under associate review了呢，有同样情况的嘛

121 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=575961, encodeId=f2915e596122, content=这是直接接受吗？修改都没有。Awaiting Associate Editor Assignment是什么意思？133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , beContent=133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44bb2184804, createdName=效率, createdTime=Sat Sep 07 00:00:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885802, encodeId=f3918858023d, content=小修修回in review15天之后突然时间一变，状态栏变得啥字也没有了是什么情况 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26812404059, createdName=RoseTiger, createdTime=Wed Sep 16 16:06:45 CST 2020, time=2020-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812568, encodeId=d6e981256825, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:1705.0 偏重的研究方向：生物医学;生物综合 经验分享：从2017-2019年的统计结果来看，国人在 Bioscience reports 期刊的发文比例高达 82.254 %，排名第1，排名第二、三的分别是美国和印度，仅仅占比6%和2%。其中国内发表较多的单位有：南京医科大学（35）、中南大学（32）、吉林大学（25）、浙江大学（23）、中山大学（22）等。 我们来看几篇今年发表的论文，平均3个月左右接受，当然有的快一些，有的相对慢一些。整体来说，发文速度还是可以的。 从期刊目前数据来看，除了发文量不断增加以外，Bioscience reports 的各项数据都比较正常，然而因为陷入论文工厂事件，期刊的口碑大大下降，甚至进入某些高校黑名单，建议近期投稿的朋友避开这些期刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Aug 23 21:58:30 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806415, encodeId=ea96806415a2, content=为啥送一审2个月后又变成under associate review了呢，有同样情况的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69c35221125, createdName=1477da0bm07暂无昵称, createdTime=Thu Aug 06 01:06:28 CST 2020, time=2020-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801258, encodeId=550e80125831, content=一审两个多月了，是不是可以催一波了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26812404059, createdName=RoseTiger, createdTime=Sat Jul 04 23:06:22 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589521, encodeId=169c589521c0, content=decision pending后多久有答复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24495253018, createdName=147e61c6m83暂无昵称, createdTime=Thu Apr 23 00:00:00 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799950, encodeId=34f1e9995041, content=作为审稿人毙了一篇纯生信的论文, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/11/496201557c66919dd52c47b9ba68d043.jpg, createdBy=6f902442791, createdName=洛洛仔, createdTime=Fri Jun 26 22:12:21 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591235, encodeId=8b30591235c6, content=这个杂志看运气，运气好，很快，运气不好，一年半载被拒也, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8657105222, createdName=科研二狗, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590839, encodeId=d24e59083931, content=好人一生pingamhanbin0827_86788705 2019-11-05 发表:: 好人一生平安hanbin0827_86788705 2019-11-05 00:00:00 发表: 好人一生平安, beContent=hanbin0827_86788705 2019-11-05 发表:: 好人一生平安, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLp7gHFr6BjdadYu5S0dib1icJX6LFccX1PH9cFmuJITRRTzaIxOvSZNIlQFKnywg2Cribd2PAbkZuGA/132, createdBy=34535244320, createdName=老鱼故事123, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590750, encodeId=aa7c590e503c, content=之后多久送审的呢？初魔 2019-07-01 16:57:00 发表: 我投了35天了，刚刚分到编辑手里边。。。。。。好慢好慢，哎, beContent=初魔 2019-07-01 16:57:00 发表: 我投了35天了，刚刚分到编辑手里边。。。。。。好慢好慢，哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLCGKsTgFGQElarkZHmPicpnkPAFa2qOHBuDT9lsYXiaibBUefKYmThJcHFj0gyrNPicmFe3Qgfw41DAA/132, createdBy=746d5311841, createdName=安琪Christine, createdTime=Wed May 13 00:00:00 CST 2020, time=2020-05-13, status=1, ipAttribution=)]

2020-07-04 RoseTiger

一审两个多月了，是不是可以催一波了?

102 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=575961, encodeId=f2915e596122, content=这是直接接受吗？修改都没有。Awaiting Associate Editor Assignment是什么意思？133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , beContent=133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44bb2184804, createdName=效率, createdTime=Sat Sep 07 00:00:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885802, encodeId=f3918858023d, content=小修修回in review15天之后突然时间一变，状态栏变得啥字也没有了是什么情况 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26812404059, createdName=RoseTiger, createdTime=Wed Sep 16 16:06:45 CST 2020, time=2020-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812568, encodeId=d6e981256825, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:1705.0 偏重的研究方向：生物医学;生物综合 经验分享：从2017-2019年的统计结果来看，国人在 Bioscience reports 期刊的发文比例高达 82.254 %，排名第1，排名第二、三的分别是美国和印度，仅仅占比6%和2%。其中国内发表较多的单位有：南京医科大学（35）、中南大学（32）、吉林大学（25）、浙江大学（23）、中山大学（22）等。 我们来看几篇今年发表的论文，平均3个月左右接受，当然有的快一些，有的相对慢一些。整体来说，发文速度还是可以的。 从期刊目前数据来看，除了发文量不断增加以外，Bioscience reports 的各项数据都比较正常，然而因为陷入论文工厂事件，期刊的口碑大大下降，甚至进入某些高校黑名单，建议近期投稿的朋友避开这些期刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Aug 23 21:58:30 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806415, encodeId=ea96806415a2, content=为啥送一审2个月后又变成under associate review了呢，有同样情况的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69c35221125, createdName=1477da0bm07暂无昵称, createdTime=Thu Aug 06 01:06:28 CST 2020, time=2020-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801258, encodeId=550e80125831, content=一审两个多月了，是不是可以催一波了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26812404059, createdName=RoseTiger, createdTime=Sat Jul 04 23:06:22 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589521, encodeId=169c589521c0, content=decision pending后多久有答复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24495253018, createdName=147e61c6m83暂无昵称, createdTime=Thu Apr 23 00:00:00 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799950, encodeId=34f1e9995041, content=作为审稿人毙了一篇纯生信的论文, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/11/496201557c66919dd52c47b9ba68d043.jpg, createdBy=6f902442791, createdName=洛洛仔, createdTime=Fri Jun 26 22:12:21 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591235, encodeId=8b30591235c6, content=这个杂志看运气，运气好，很快，运气不好，一年半载被拒也, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8657105222, createdName=科研二狗, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590839, encodeId=d24e59083931, content=好人一生pingamhanbin0827_86788705 2019-11-05 发表:: 好人一生平安hanbin0827_86788705 2019-11-05 00:00:00 发表: 好人一生平安, beContent=hanbin0827_86788705 2019-11-05 发表:: 好人一生平安, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLp7gHFr6BjdadYu5S0dib1icJX6LFccX1PH9cFmuJITRRTzaIxOvSZNIlQFKnywg2Cribd2PAbkZuGA/132, createdBy=34535244320, createdName=老鱼故事123, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590750, encodeId=aa7c590e503c, content=之后多久送审的呢？初魔 2019-07-01 16:57:00 发表: 我投了35天了，刚刚分到编辑手里边。。。。。。好慢好慢，哎, beContent=初魔 2019-07-01 16:57:00 发表: 我投了35天了，刚刚分到编辑手里边。。。。。。好慢好慢，哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLCGKsTgFGQElarkZHmPicpnkPAFa2qOHBuDT9lsYXiaibBUefKYmThJcHFj0gyrNPicmFe3Qgfw41DAA/132, createdBy=746d5311841, createdName=安琪Christine, createdTime=Wed May 13 00:00:00 CST 2020, time=2020-05-13, status=1, ipAttribution=)]

2020-04-23 147e61c6m83暂无昵称

decision pending后多久有答复

100 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=575961, encodeId=f2915e596122, content=这是直接接受吗？修改都没有。Awaiting Associate Editor Assignment是什么意思？133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , beContent=133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44bb2184804, createdName=效率, createdTime=Sat Sep 07 00:00:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885802, encodeId=f3918858023d, content=小修修回in review15天之后突然时间一变，状态栏变得啥字也没有了是什么情况 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26812404059, createdName=RoseTiger, createdTime=Wed Sep 16 16:06:45 CST 2020, time=2020-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812568, encodeId=d6e981256825, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:1705.0 偏重的研究方向：生物医学;生物综合 经验分享：从2017-2019年的统计结果来看，国人在 Bioscience reports 期刊的发文比例高达 82.254 %，排名第1，排名第二、三的分别是美国和印度，仅仅占比6%和2%。其中国内发表较多的单位有：南京医科大学（35）、中南大学（32）、吉林大学（25）、浙江大学（23）、中山大学（22）等。 我们来看几篇今年发表的论文，平均3个月左右接受，当然有的快一些，有的相对慢一些。整体来说，发文速度还是可以的。 从期刊目前数据来看，除了发文量不断增加以外，Bioscience reports 的各项数据都比较正常，然而因为陷入论文工厂事件，期刊的口碑大大下降，甚至进入某些高校黑名单，建议近期投稿的朋友避开这些期刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Aug 23 21:58:30 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806415, encodeId=ea96806415a2, content=为啥送一审2个月后又变成under associate review了呢，有同样情况的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69c35221125, createdName=1477da0bm07暂无昵称, createdTime=Thu Aug 06 01:06:28 CST 2020, time=2020-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801258, encodeId=550e80125831, content=一审两个多月了，是不是可以催一波了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26812404059, createdName=RoseTiger, createdTime=Sat Jul 04 23:06:22 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589521, encodeId=169c589521c0, content=decision pending后多久有答复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24495253018, createdName=147e61c6m83暂无昵称, createdTime=Thu Apr 23 00:00:00 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799950, encodeId=34f1e9995041, content=作为审稿人毙了一篇纯生信的论文, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/11/496201557c66919dd52c47b9ba68d043.jpg, createdBy=6f902442791, createdName=洛洛仔, createdTime=Fri Jun 26 22:12:21 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591235, encodeId=8b30591235c6, content=这个杂志看运气，运气好，很快，运气不好，一年半载被拒也, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8657105222, createdName=科研二狗, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590839, encodeId=d24e59083931, content=好人一生pingamhanbin0827_86788705 2019-11-05 发表:: 好人一生平安hanbin0827_86788705 2019-11-05 00:00:00 发表: 好人一生平安, beContent=hanbin0827_86788705 2019-11-05 发表:: 好人一生平安, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLp7gHFr6BjdadYu5S0dib1icJX6LFccX1PH9cFmuJITRRTzaIxOvSZNIlQFKnywg2Cribd2PAbkZuGA/132, createdBy=34535244320, createdName=老鱼故事123, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590750, encodeId=aa7c590e503c, content=之后多久送审的呢？初魔 2019-07-01 16:57:00 发表: 我投了35天了，刚刚分到编辑手里边。。。。。。好慢好慢，哎, beContent=初魔 2019-07-01 16:57:00 发表: 我投了35天了，刚刚分到编辑手里边。。。。。。好慢好慢，哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLCGKsTgFGQElarkZHmPicpnkPAFa2qOHBuDT9lsYXiaibBUefKYmThJcHFj0gyrNPicmFe3Qgfw41DAA/132, createdBy=746d5311841, createdName=安琪Christine, createdTime=Wed May 13 00:00:00 CST 2020, time=2020-05-13, status=1, ipAttribution=)]

2020-06-26 洛洛仔

作为审稿人毙了一篇纯生信的论文

98 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=575961, encodeId=f2915e596122, content=这是直接接受吗？修改都没有。Awaiting Associate Editor Assignment是什么意思？133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , beContent=133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44bb2184804, createdName=效率, createdTime=Sat Sep 07 00:00:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885802, encodeId=f3918858023d, content=小修修回in review15天之后突然时间一变，状态栏变得啥字也没有了是什么情况 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26812404059, createdName=RoseTiger, createdTime=Wed Sep 16 16:06:45 CST 2020, time=2020-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812568, encodeId=d6e981256825, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:1705.0 偏重的研究方向：生物医学;生物综合 经验分享：从2017-2019年的统计结果来看，国人在 Bioscience reports 期刊的发文比例高达 82.254 %，排名第1，排名第二、三的分别是美国和印度，仅仅占比6%和2%。其中国内发表较多的单位有：南京医科大学（35）、中南大学（32）、吉林大学（25）、浙江大学（23）、中山大学（22）等。 我们来看几篇今年发表的论文，平均3个月左右接受，当然有的快一些，有的相对慢一些。整体来说，发文速度还是可以的。 从期刊目前数据来看，除了发文量不断增加以外，Bioscience reports 的各项数据都比较正常，然而因为陷入论文工厂事件，期刊的口碑大大下降，甚至进入某些高校黑名单，建议近期投稿的朋友避开这些期刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Aug 23 21:58:30 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806415, encodeId=ea96806415a2, content=为啥送一审2个月后又变成under associate review了呢，有同样情况的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69c35221125, createdName=1477da0bm07暂无昵称, createdTime=Thu Aug 06 01:06:28 CST 2020, time=2020-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801258, encodeId=550e80125831, content=一审两个多月了，是不是可以催一波了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26812404059, createdName=RoseTiger, createdTime=Sat Jul 04 23:06:22 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589521, encodeId=169c589521c0, content=decision pending后多久有答复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24495253018, createdName=147e61c6m83暂无昵称, createdTime=Thu Apr 23 00:00:00 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799950, encodeId=34f1e9995041, content=作为审稿人毙了一篇纯生信的论文, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/11/496201557c66919dd52c47b9ba68d043.jpg, createdBy=6f902442791, createdName=洛洛仔, createdTime=Fri Jun 26 22:12:21 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591235, encodeId=8b30591235c6, content=这个杂志看运气，运气好，很快，运气不好，一年半载被拒也, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8657105222, createdName=科研二狗, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590839, encodeId=d24e59083931, content=好人一生pingamhanbin0827_86788705 2019-11-05 发表:: 好人一生平安hanbin0827_86788705 2019-11-05 00:00:00 发表: 好人一生平安, beContent=hanbin0827_86788705 2019-11-05 发表:: 好人一生平安, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLp7gHFr6BjdadYu5S0dib1icJX6LFccX1PH9cFmuJITRRTzaIxOvSZNIlQFKnywg2Cribd2PAbkZuGA/132, createdBy=34535244320, createdName=老鱼故事123, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590750, encodeId=aa7c590e503c, content=之后多久送审的呢？初魔 2019-07-01 16:57:00 发表: 我投了35天了，刚刚分到编辑手里边。。。。。。好慢好慢，哎, beContent=初魔 2019-07-01 16:57:00 发表: 我投了35天了，刚刚分到编辑手里边。。。。。。好慢好慢，哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLCGKsTgFGQElarkZHmPicpnkPAFa2qOHBuDT9lsYXiaibBUefKYmThJcHFj0gyrNPicmFe3Qgfw41DAA/132, createdBy=746d5311841, createdName=安琪Christine, createdTime=Wed May 13 00:00:00 CST 2020, time=2020-05-13, status=1, ipAttribution=)]

2020-05-19 科研二狗

这个杂志看运气，运气好，很快，运气不好，一年半载被拒也

94 0

[GetPortalCommentsPageByObjectIdResponse(id=575961, encodeId=f2915e596122, content=这是直接接受吗？修改都没有。Awaiting Associate Editor Assignment是什么意思？133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , beContent=133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44bb2184804, createdName=效率, createdTime=Sat Sep 07 00:00:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885802, encodeId=f3918858023d, content=小修修回in review15天之后突然时间一变，状态栏变得啥字也没有了是什么情况 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26812404059, createdName=RoseTiger, createdTime=Wed Sep 16 16:06:45 CST 2020, time=2020-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812568, encodeId=d6e981256825, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:1705.0 偏重的研究方向：生物医学;生物综合 经验分享：从2017-2019年的统计结果来看，国人在 Bioscience reports 期刊的发文比例高达 82.254 %，排名第1，排名第二、三的分别是美国和印度，仅仅占比6%和2%。其中国内发表较多的单位有：南京医科大学（35）、中南大学（32）、吉林大学（25）、浙江大学（23）、中山大学（22）等。 我们来看几篇今年发表的论文，平均3个月左右接受，当然有的快一些，有的相对慢一些。整体来说，发文速度还是可以的。 从期刊目前数据来看，除了发文量不断增加以外，Bioscience reports 的各项数据都比较正常，然而因为陷入论文工厂事件，期刊的口碑大大下降，甚至进入某些高校黑名单，建议近期投稿的朋友避开这些期刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Aug 23 21:58:30 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806415, encodeId=ea96806415a2, content=为啥送一审2个月后又变成under associate review了呢，有同样情况的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69c35221125, createdName=1477da0bm07暂无昵称, createdTime=Thu Aug 06 01:06:28 CST 2020, time=2020-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801258, encodeId=550e80125831, content=一审两个多月了，是不是可以催一波了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26812404059, createdName=RoseTiger, createdTime=Sat Jul 04 23:06:22 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589521, encodeId=169c589521c0, content=decision pending后多久有答复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24495253018, createdName=147e61c6m83暂无昵称, createdTime=Thu Apr 23 00:00:00 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799950, encodeId=34f1e9995041, content=作为审稿人毙了一篇纯生信的论文, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/11/496201557c66919dd52c47b9ba68d043.jpg, createdBy=6f902442791, createdName=洛洛仔, createdTime=Fri Jun 26 22:12:21 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591235, encodeId=8b30591235c6, content=这个杂志看运气，运气好，很快，运气不好，一年半载被拒也, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8657105222, createdName=科研二狗, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590839, encodeId=d24e59083931, content=好人一生pingamhanbin0827_86788705 2019-11-05 发表:: 好人一生平安hanbin0827_86788705 2019-11-05 00:00:00 发表: 好人一生平安, beContent=hanbin0827_86788705 2019-11-05 发表:: 好人一生平安, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLp7gHFr6BjdadYu5S0dib1icJX6LFccX1PH9cFmuJITRRTzaIxOvSZNIlQFKnywg2Cribd2PAbkZuGA/132, createdBy=34535244320, createdName=老鱼故事123, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590750, encodeId=aa7c590e503c, content=之后多久送审的呢？初魔 2019-07-01 16:57:00 发表: 我投了35天了，刚刚分到编辑手里边。。。。。。好慢好慢，哎, beContent=初魔 2019-07-01 16:57:00 发表: 我投了35天了，刚刚分到编辑手里边。。。。。。好慢好慢，哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLCGKsTgFGQElarkZHmPicpnkPAFa2qOHBuDT9lsYXiaibBUefKYmThJcHFj0gyrNPicmFe3Qgfw41DAA/132, createdBy=746d5311841, createdName=安琪Christine, createdTime=Wed May 13 00:00:00 CST 2020, time=2020-05-13, status=1, ipAttribution=)]

2020-05-14 老鱼故事123

好人一生pingamhanbin0827_86788705 2019-11-05 发表::
好人一生平安hanbin0827_86788705 2019-11-05 00:00:00 发表:
好人一生平安

hanbin0827_86788705 2019-11-05 发表:: 好人一生平安

69 0

[GetPortalCommentsPageByObjectIdResponse(id=575961, encodeId=f2915e596122, content=这是直接接受吗？修改都没有。Awaiting Associate Editor Assignment是什么意思？133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , beContent=133****4826暂无昵称 2019-05-30 00:00:00 发表: CCC Finished 19th Apr 19 06:41:24 CCC Publisher Accept 17th Apr 19 23:17:09 Awaiting Acceptance Payment 17th Apr 19 23:17:09 Decision Sent to Author 17th Apr 19 23:17:08 In review 17th Apr 19 12:55:25 Manuscript Accepted 17th Apr 19 12:55:25 Decision Pending 17th Apr 19 12:55:25 Under Associate Editor Review 14th Apr 19 15:25:52 In review 8th Apr 19 13:08:34 Author Approved Converted Files 8th Apr 19 13:08:34 Preliminary Manuscript Data Submitted 8th Apr 19 04:31:04 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44bb2184804, createdName=效率, createdTime=Sat Sep 07 00:00:00 CST 2019, time=2019-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885802, encodeId=f3918858023d, content=小修修回in review15天之后突然时间一变，状态栏变得啥字也没有了是什么情况 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26812404059, createdName=RoseTiger, createdTime=Wed Sep 16 16:06:45 CST 2020, time=2020-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812568, encodeId=d6e981256825, content=审稿速度:1.0 | 投稿命中率:75.0 | 版面费用:1705.0 偏重的研究方向：生物医学;生物综合 经验分享：从2017-2019年的统计结果来看，国人在 Bioscience reports 期刊的发文比例高达 82.254 %，排名第1，排名第二、三的分别是美国和印度，仅仅占比6%和2%。其中国内发表较多的单位有：南京医科大学（35）、中南大学（32）、吉林大学（25）、浙江大学（23）、中山大学（22）等。 我们来看几篇今年发表的论文，平均3个月左右接受，当然有的快一些，有的相对慢一些。整体来说，发文速度还是可以的。 从期刊目前数据来看，除了发文量不断增加以外，Bioscience reports 的各项数据都比较正常，然而因为陷入论文工厂事件，期刊的口碑大大下降，甚至进入某些高校黑名单，建议近期投稿的朋友避开这些期刊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Aug 23 21:58:30 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806415, encodeId=ea96806415a2, content=为啥送一审2个月后又变成under associate review了呢，有同样情况的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69c35221125, createdName=1477da0bm07暂无昵称, createdTime=Thu Aug 06 01:06:28 CST 2020, time=2020-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801258, encodeId=550e80125831, content=一审两个多月了，是不是可以催一波了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26812404059, createdName=RoseTiger, createdTime=Sat Jul 04 23:06:22 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589521, encodeId=169c589521c0, content=decision pending后多久有答复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24495253018, createdName=147e61c6m83暂无昵称, createdTime=Thu Apr 23 00:00:00 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799950, encodeId=34f1e9995041, content=作为审稿人毙了一篇纯生信的论文, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/11/496201557c66919dd52c47b9ba68d043.jpg, createdBy=6f902442791, createdName=洛洛仔, createdTime=Fri Jun 26 22:12:21 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591235, encodeId=8b30591235c6, content=这个杂志看运气，运气好，很快，运气不好，一年半载被拒也, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8657105222, createdName=科研二狗, createdTime=Tue May 19 00:00:00 CST 2020, time=2020-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590839, encodeId=d24e59083931, content=好人一生pingamhanbin0827_86788705 2019-11-05 发表:: 好人一生平安hanbin0827_86788705 2019-11-05 00:00:00 发表: 好人一生平安, beContent=hanbin0827_86788705 2019-11-05 发表:: 好人一生平安, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLp7gHFr6BjdadYu5S0dib1icJX6LFccX1PH9cFmuJITRRTzaIxOvSZNIlQFKnywg2Cribd2PAbkZuGA/132, createdBy=34535244320, createdName=老鱼故事123, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590750, encodeId=aa7c590e503c, content=之后多久送审的呢？初魔 2019-07-01 16:57:00 发表: 我投了35天了，刚刚分到编辑手里边。。。。。。好慢好慢，哎, beContent=初魔 2019-07-01 16:57:00 发表: 我投了35天了，刚刚分到编辑手里边。。。。。。好慢好慢，哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLCGKsTgFGQElarkZHmPicpnkPAFa2qOHBuDT9lsYXiaibBUefKYmThJcHFj0gyrNPicmFe3Qgfw41DAA/132, createdBy=746d5311841, createdName=安琪Christine, createdTime=Wed May 13 00:00:00 CST 2020, time=2020-05-13, status=1, ipAttribution=)]

2020-05-13 安琪Christine

之后多久送审的呢？初魔 2019-07-01 16:57:00 发表:
我投了35天了，刚刚分到编辑手里边。。。。。。好慢好慢，哎

初魔 2019-07-01 16:57:00 发表: 我投了35天了，刚刚分到编辑手里边。。。。。。好慢好慢，哎

73 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务